
TY  - JOUR
TI  - Poster Absracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 107
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12155
DO  - doi:10.1111/vox.12155
SP  - 57
EP  - 248
PY  - 2014
ER  - 

AU  - Logan, Sarah
AU  - Arzua, Thiago
AU  - Canfield, Scott G.
AU  - Seminary, Emily R.
AU  - Sison, Samantha L.
AU  - Ebert, Allison D.
AU  - Bai, Xiaowen
C7  - pp. 565-611
TI  - Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
UR  - https://doi.org/10.1002/cphy.c180025
DO  - doi:10.1002/cphy.c180025
SP  - 565-611
PY  - 2014
AB  - ABSTRACT Neurological disorders have emerged as a predominant healthcare concern in recent years due to their severe consequences on quality of life and prevalence throughout the world. Understanding the underlying mechanisms of these diseases and the interactions between different brain cell types is essential for the development of new therapeutics. Induced pluripotent stem cells (iPSCs) are invaluable tools for neurological disease modeling, as they have unlimited self-renewal and differentiation capacity. Mounting evidence shows: (i) various brain cells can be generated from iPSCs in two-dimensional (2D) monolayer cultures; and (ii) further advances in 3D culture systems have led to the differentiation of iPSCs into organoids with multiple brain cell types and specific brain regions. These 3D organoids have gained widespread attention as in vitro tools to recapitulate complex features of the brain, and (iii) complex interactions between iPSC-derived brain cell types can recapitulate physiological and pathological conditions of blood-brain barrier (BBB). As iPSCs can be generated from diverse patient populations, researchers have effectively applied 2D, 3D, and BBB models to recapitulate genetically complex neurological disorders and reveal novel insights into molecular and genetic mechanisms of neurological disorders. In this review, we describe recent progress in the generation of 2D, 3D, and BBB models from iPSCs and further discuss their limitations, advantages, and future ventures. This review also covers the current status of applications of 2D, 3D, and BBB models in drug screening, precision medicine, and modeling a wide range of neurological diseases (e.g., neurodegenerative diseases, neurodevelopmental disorders, brain injury, and neuropsychiatric disorders). ? 2019 American Physiological Society. Compr Physiol 9:565-611, 2019.
ER  - 

TY  - JOUR
TI  - Contents, Volume 69, 2017
JO  - Arthritis & Rheumatology
JA  - Arthritis Rheumatol
VL  - 69
IS  - 12
UR  - https://doi.org/10.1002/art.40374
DO  - doi:10.1002/art.40374
SP  - 2411
EP  - 2436
PY  - 2017
ER  - 

TY  - JOUR
TI  - Masthead and Table of Contents
JO  - Transfusion
JA  - Transfusion
VL  - 59
IS  - 1
UR  - https://doi.org/10.1111/trf.14844
DO  - doi:10.1111/trf.14844
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Session II: October 1 (12pm) - October 2
JO  - Journal of Neurochemistry
VL  - 123
IS  - s1
UR  - https://doi.org/10.1111/j.1471-4159.2012.07906.x
DO  - doi:10.1111/j.1471-4159.2012.07906.x
SP  - 89
EP  - 128
PY  - 2012
ER  - 

TY  - JOUR
TI  - ICVM-8 abstracts
JO  - Journal of Morphology
JA  - J. Morphol.
VL  - 268
IS  - 12
UR  - https://doi.org/10.1002/jmor.10589
DO  - doi:10.1002/jmor.10589
SP  - 1042
EP  - 1154
PY  - 2007
ER  - 

TY  - JOUR
TI  - Oral Abstract Sessions
JO  - Allergy
JA  - Allergy
VL  - 68
IS  - s97
UR  - https://doi.org/10.1111/all.12247
DO  - doi:10.1111/all.12247
SP  - 1
EP  - 104
PY  - 2013
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 19
IS  - S1
UR  - https://doi.org/10.1111/1751-2980.12664
DO  - doi:10.1111/1751-2980.12664
SP  - 12
EP  - 48
PY  - 2018
ER  - 

TY  - JOUR
TI  - Conference Program
JO  - Medical Physics
JA  - Med. Phys.
VL  - 46
IS  - 6
UR  - https://doi.org/10.1002/mp.13596
DO  - doi:10.1002/mp.13596
SP  - 2782
EP  - 2883
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Sessions
JO  - Transplant International
VL  - 24
IS  - s2
UR  - https://doi.org/10.1111/j.1432-2277.2011.01346.x
DO  - doi:10.1111/j.1432-2277.2011.01346.x
SP  - 1
EP  - 95
PY  - 2011
ER  - 

TY  - JOUR
TI  - Friday Poster Session
JO  - Journal of Neurochemistry
VL  - 110
IS  - s2
UR  - https://doi.org/10.1111/j.1471-4159.2009.06244.x
DO  - doi:10.1111/j.1471-4159.2009.06244.x
SP  - 227
EP  - 269
PY  - 2009
ER  - 

TY  - JOUR
TI  - List of Abstracts
JO  - Movement Disorders
JA  - Mov Disord.
VL  - 30
IS  - S1
UR  - https://doi.org/10.1002/mds.26296
DO  - doi:10.1002/mds.26296
SP  - S568
EP  - S633
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Pediatric Diabetes
JA  - Pediatric Diabetes
VL  - 16
IS  - S21
UR  - https://doi.org/10.1111/pedi.12309
DO  - doi:10.1111/pedi.12309
SP  - 50
EP  - 150
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 130
IS  - s1
UR  - https://doi.org/10.1111/jnc.12778
DO  - doi:10.1111/jnc.12778
SP  - 46
EP  - 75
PY  - 2014
ER  - 

TY  - JOUR
AU  - Kundu, Roopal V.
AU  - Mhlaba, Julia M.
AU  - Rangel, Stephanie M.
AU  - Le Poole, I. Caroline
TI  - The convergence theory for vitiligo: A reappraisal
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 28
IS  - 6
UR  - https://doi.org/10.1111/exd.13677
DO  - doi:10.1111/exd.13677
SP  - 647
EP  - 655
KW  - autoimmune
KW  - depigmentation
KW  - melanocyte
KW  - vitiligo aetiology
PY  - 2019
AB  - Abstract Vitiligo is characterized by progressive loss of skin pigmentation. The search for aetiologic factors has led to the biochemical, the neurologic and the autoimmune theory. The convergence theory was then proposed several years ago to incorporate existing theories of vitiligo development into a single overview of vitiligo aetiology. The viewpoint that vitiligo is not caused only by predisposing mutations, or only by melanocytes responding to chemical/radiation exposure, or only by hyperreactive T cells, but rather results from a combination of aetiologic factors that impact melanocyte viability, has certainly stood the test of time. New findings have since informed the description of progressive depigmentation. Understanding the relative importance of such aetiologic factors combined with a careful selection of the most targetable pathways will continue to drive the next phase in vitiligo research: the development of effective therapeutics. In that arena, it is likewise important to acknowledge that pathways affected in some patients may not be altered in others. Taken together, the convergence theory continues to provide a comprehensive viewpoint of vitiligo aetiology. The theory serves to intertwine aetiologic pathways and will help to define pathways amenable to disease intervention in individual patients.
ER  - 

TY  - JOUR
TI  - Plenary Sessions
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 125
IS  - S4
UR  - https://doi.org/10.1111/bcpt.13301
DO  - doi:10.1111/bcpt.13301
SP  - 4
EP  - 55
PY  - 2019
ER  - 

TY  - JOUR
TI  - Paper Poster Sessions
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 21
IS  - s1
UR  - https://doi.org/10.1111/ene.12497
DO  - doi:10.1111/ene.12497
SP  - 388
EP  - 713
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Colorectal Disease
VL  - 13
IS  - s4
UR  - https://doi.org/10.1111/j.1463-1318.2011.02660.x
DO  - doi:10.1111/j.1463-1318.2011.02660.x
SP  - 1
EP  - 14
PY  - 2011
ER  - 

TY  - JOUR
TI  - ABSTRACTS—SYMPOSIA
JO  - Alcoholism: Clinical and Experimental Research
VL  - 32
IS  - s1
UR  - https://doi.org/10.1111/j.1530-0277.2008.00684.x-i1
DO  - doi:10.1111/j.1530-0277.2008.00684.x-i1
SP  - 273A
EP  - 345A
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abtracts
JO  - Journal of Medical Primatology
JA  - J Med Primatol
VL  - 45
IS  - 5
UR  - https://doi.org/10.1111/jmp.12245
DO  - doi:10.1111/jmp.12245
SP  - 222
EP  - 274
PY  - 2016
ER  - 
